Pearson Nurse's Drug Guide 2014

(3)
Pearson Nurse's Drug Guide 2014 image
ISBN-10:

0133357317

ISBN-13:

9780133357318

Edition: 1
Released: Apr 18, 2013
Publisher: Pearson
Format: Paperback, 1790 pages
Related ISBN: 9780133355529

Description:

With over 350 updates, the new 2014 edition of the Pearson Nurse’s Drug Guide provides safe, effective, current, and accurate drug information in a quickly accessible format. Comprehensive and complete, it lists all drugs alphabetically by generic names for quick reference, with an index listing both generic and trade names. It presents important clinical information for hundreds of drugs, with adverse reactions, interactions, side effects, and impacts on lab results. It clearly presents information on IV preparation and push, continuous, or intermittent administration; as well as dosages for neonates, infants, adolescents, adults, and patients with obesity and renal or hepatic impairment. This edition also contains 21 brand-new monographs for drugs recently approved by the FDA.

Best prices to buy, sell, or rent ISBN 9780133357318




Frequently Asked Questions about Pearson Nurse's Drug Guide 2014

You can buy the Pearson Nurse's Drug Guide 2014 book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .

The price for the book starts from $6.33 on Amazon and is available from 5 sellers at the moment.

If you’re interested in selling back the Pearson Nurse's Drug Guide 2014 book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.

As for the Pearson Nurse's Drug Guide 2014 book, the best buyback offer comes from and is $ for the book in good condition.

The Pearson Nurse's Drug Guide 2014 book is in very low demand now as the rank for the book is 7,677,924 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.

Not enough insights yet.